Market Paradox: Nektar Therapeutics’ Legal Win Against Eli Lilly Fails to Ignite Investor Confidence
This past week, the biotechnology sector witnessed a rare and counterintuitive phenomenon: a significant courtroom victory that translated into a...
This past week, the biotechnology sector witnessed a rare and counterintuitive phenomenon: a significant courtroom victory that translated into a...
Novartis, the Swiss pharmaceutical titan, is currently grappling with more than just the $30 billion evaporation of its market capitalization...